The Brighterside of News on MSN

First human trial of a CRISPR-based treatment significantly lowered cholesterol and triglycerides

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success with a new kind of treatment that works with only one infusion. The ...
Seeking Alpha

First Human Crispr Trial Is A Go, But Don't Ask About The IP

Yesterday’s near-unanimous expert vote brings the West’s first human trial to use the Crispr gene-editing technique a step closer to reality. But the riddle of who from a complex web of interested ...
Morningstar

GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World's First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational ...

The first patient, who received GEB-101 in May 2025, has been discharged from the collaborating hospital with no observable adverse event. This trial marks the world's first clinical study of an in ...
Morningstar

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

We are highly encouraged by the initial data from our Phase 1 trial for CTX310, which demonstrates the power of our in vivo gene editing platform to deliver paradigm changing medicines to patients ...
MLive

First CRISPR trial in humans will attempt to battle lung cancer

The first human trial of cells that have been tweaked by the genome-editing technique CRISPR will begin in China in August, Nature reports. The group will take white blood cells, which are part of the ...
Irish Medical Times

“I’ve been so lucky” – Irish woman who became first recipient of gene-editing therapy

Five years on from being the first person in the world to receive intravenous CRISPR treatment, Westmeath woman describes the clinical trial she participated in as ‘life-changing’ ...